Avalo Therapeutics (FRA:C6K0) 3-Year Revenue Growth Rate : -71.30% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Avalo Therapeutics 3-Year Revenue Growth Rate?

Avalo Therapeutics's Revenue per Share for the three months ended in Dec. 2023 was €0.65.

During the past 12 months, Avalo Therapeutics's average Revenue per Share Growth Rate was -98.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -71.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -47.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Avalo Therapeutics was 5.40% per year. The lowest was -71.30% per year. And the median was -36.50% per year.

Competitive Comparison of Avalo Therapeutics's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Avalo Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avalo Therapeutics's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Avalo Therapeutics's 3-Year Revenue Growth Rate falls into.

Avalo Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Avalo Therapeutics (FRA:C6K0) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Avalo Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Avalo Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Avalo Therapeutics (FRA:C6K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (FRA:C6K0) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

AVTX:USA C6K0:Germany

Address

540 Gaither Road, Suite 400, Rockville, MD, USA, 20850

Website

https://www.avalotx.com

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Avalo Therapeutics (FRA:C6K0) Headlines

No Headlines